Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.
2 registered trials, newest registry update first. Showing only trials linked to Ipamorelin.
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus NCT00672074 | Ipamorelin | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 117 | Dec 2009 | Apr 14, 2017 |
| Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function NCT01280344 | Ipamorelin | Phase 2 | Completed | Helsinn Therapeutics (U.S.), Inc | 320 | Jun 2013 | Apr 13, 2017 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.
